Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026
October 5, 2026 |
For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society for Medical Oncology (ESMO 2026), that commitment will be on full display. Our presence reflects a long-standing view that oncology remains one of the most urgent, highest-impact specialties in medicine and deserves education built to match.
This article outlines Medscape’s focus for the congress and its ongoing work to address identified educational gaps in oncology care.
Closing the Gap in Precision Oncology: Our Strategic Priority
Precision oncology is the frontline of individualized patient care. However, while scientific progress in novel targets and tumor-agnostic therapies is moving at a breakneck pace, the gap in precision oncology—the challenge of interpreting complex data at the point of care, remains a hurdle for many healthcare professionals.
One of our missions at ESMO 2026 is to bridge this gap by providing clinicians with unbiased, comprehensive, practical education through PIONEER, our Precision Oncology Learning Center. We aim to translate complex data into clinical delivery, ensuring that every precision oncology treatment approach reaches the patient who needs it most.
Driving Dialogue and Discovery at ESMO 2026
Medscape’s presence at ESMO is intended to facilitate discussion of emerging evidence, clinician learning needs, and educational approaches in oncology.
- Demo the PIONEER Learning Center at Booth #8072: A cross-disciplinary space for exploration and expert-led discussion where attendees can view a live demo of the learning center on screen. Advised by a steering committee of global leaders, this learning center offers structured resources designed to bridge the gap between scientific discovery and clinical execution. This booth demonstration is not accredited.
- Attend 3 Scientific Symposia: Medscape will host independently developed sessions across the congress, providing comprehensive, cross-functional, data- and case-driven education where live (and virtual) attendees can engage with the latest evidence in a way that informs their daily practice. Consult the individual session listings for objectives, faculty, and credit availability.
- View 3 Scientific Posters: At this year’s congress, Medscape will showcase data-driven insights into clinician knowledge gaps and educational efficacy to advance patient care. Highlighted presentations include studies evaluating online continuing medical education in HER2-targeted therapies for gastric/gastroesophageal junction cancers, multidisciplinary knowledge and confidence in first-line immunotherapies for squamous cell anal carcinoma , and a multitumor assessment of oncologists’ clinical application of emerging LAG-3-targeted therapies.
Our commitment is steadfast: to support oncology specialists throughout their clinical journey whether they are translating complex data at the bench, synthesizing new evidence for the bedside, or engaging in collaborative dialogue that shapes the future of cancer care.
The Impact of Medscape’s Oncology Education
At the heart of our work is a relentless focus on improving patient outcomes. Every metric we track is a proxy for improved care. See our impact in oncology education since 2025:
- 253,180 oncology healthcare professionals reached globally
- 543,070 oncology learners engaged across our oncology programs, with advanced-level outcomes assessed using our proprietary Linked Learner Assessment methodology
- 92% of learners would recommend these activities to others; 93% say the content learned from these activities will impact their practice
- 52% improvement in knowledge/competence and 32% increase in learner confidence following advanced-outcomes programming
- An estimated more than 16 million patient visits impacted every month by Medscape’s oncology education, a reminder that every learner reached is connected to real patients downstream
Source: Medscape internal data 2025.
This impact forms the foundation of what we want to achieve at ESMO 2026, continuing an evidence-based mission refined over 3 decades—now enhanced by AI tools to better serve the oncology community.
Oncology is a rapidly evolving field where clinicians make critical, life-altering decisions daily. At ESMO 2026, we are dedicated to supporting those decisions through our symposia and learning center, providing the rigorous, unbiased education that oncology professionals rely on.
We look forward to seeing you there.
For more information on Medscape’s oncology education, please reach out to your Medscape Education representative.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026
For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society…
Using AI Responsibly in CME Outcomes Reporting
ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a significant amount of background teaching,…
The Pulse of AI Innovation: From More Data to Better Care
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…
From Booth to Bavaria: A Recap of Impact at ESC 2026
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…
Why Modern Dermatology Demands Curiosity Over Precision
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC…
More Than Pink Walls: What Women-Centric Care Actually Requires
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…